FindTrial
Sign In

Real-time semi-quantification of endoscopic ultrasound elastography and contrast-enhancement using strain histograms (SH) and contrast-enhancement (CE) for the differentiation of focal pancreatic masses and the assessment of lymph node involvement:Multi-center study

Real-time semi-quantification of endoscopic ultrasound elastography and contrast-enhancement using strain histograms (SH) and contrast-enhancement (CE) for the differentiation of focal pancreatic masses and the assessment of lymph node involvement:Multi-center study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-15005853
Enrollment
Unknown
Registered
2015-01-14
Start date
2015-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic masses

Interventions

1:EUS-FNA and CE-EUS

Sponsors

Shenjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with solid pancreatic tumor masses, with cytological/histological confirmation; 2. Patients with or without suspected lymph node involvement are eligible; 3. Age 18 to 90 years old, men or women; 4. Signed informed consent for EG-EUS, CE-EUS and FNA biopsy.

Exclusion criteria

Exclusion criteria: 1. Prior surgical treatment with curative intent or chemo-radiotherapy; 2. Patients diagnosed with mucin producing tumors, pancreatic cystic tumors, etc.

Design outcomes

Primary

MeasureTime frame
blood;tissue of puncture;—

Countries

China

Contacts

Public ContactSun Siyu
sun-siyu@163.com+86 18940251329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026